4th Immune Effector Cell Therapies in Multiple Myeloma Workshop
Virtual Access to the 4th Immune Effector Cell Therapies in Multiple Myeloma Workshop will be available through April 22.
If you were unable to attend this meeting, there is still time to register and watch the video content.
Building upon the success of prior workshops, the International Myeloma Society is happy to host the 4th Immune Effector Cell Therapies in Multiple Myeloma Workshop to discuss immune-based therapies in myeloma including the latest CAR T cell and bispecific T cell-engager clinical data, promising preclinical leads, updated correlative analyses exploring predictors of response and resistance mechanisms, and next-generation manufacturing and CAR construct approaches, including “off-the-shelf” allogeneic and NK-cell based strategies. This year we are also including a session on real-world considerations, including how to potentially sequence immune-based therapies for myeloma, as well as best practices for infection prevention following T cell-directed therapies.
Program
Our sponsors:
Titanium
Platinum
Silver
Registration Rates
| Registration Category | Virtual Rate | |
| Member | $0.00 | |
| Non-Member | $100.00 | |
| Non-Members in Training | $50.00 | |
| Pharma Industry | $150.00 |
